(Q33384024)

English

Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124. (English)

1 reference

Europe PubMed Central

26 July 2017

phase III clinical trial

0 references

pharmacogenomics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

David R Gandara

12

object named as

David R Gandara

1 reference

Europe PubMed Central

26 July 2017

Heinz-Josef Lenz

4

object named as

Heinz Josef Lenz

1 reference

Europe PubMed Central

26 July 2017

7

object named as

James Jett

1 reference

Europe PubMed Central

26 July 2017

8

object named as

Corey J Langer

1 reference

Europe PubMed Central

26 July 2017

author name string

Primo N Lara

1

1 reference

Europe PubMed Central

26 July 2017

Ronald Natale

2

1 reference

Europe PubMed Central

26 July 2017

John Crowley

3

1 reference

Europe PubMed Central

26 July 2017

Mary W Redman

5

1 reference

Europe PubMed Central

26 July 2017

Jane E Carleton

6

1 reference

Europe PubMed Central

26 July 2017

J Philip Kuebler

9

1 reference

Europe PubMed Central

26 July 2017

Shaker R Dakhil

10

1 reference

Europe PubMed Central

26 July 2017

Kari Chansky

11

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

6 April 2009

1 reference

Europe PubMed Central

26 July 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

26 July 2017

27

1 reference

Europe PubMed Central

26 July 2017

2530-2535

1 reference

Europe PubMed Central

26 July 2017

15

1 reference

Europe PubMed Central

26 July 2017

Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Randomized trials in oncology stopped early for benefit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Pharmacogenetics of colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

ABCG2 pharmacogenetics: ethnic differences in allele frequency and assessment of influence on irinotecan disposition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Pharmacogenetics in cancer chemotherapy: balancing toxicity and response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Small cell lung cancer: state of the art and future perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Treatment of extensive small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Cancer pharmacogenomics: current and future applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

21 June 2018

Irinotecan pharmacogenetics: influence of pharmacodynamic genes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

31 October 2018

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

31 October 2018

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2684855

31 October 2018

Pharmacogenomics and colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19349543

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progress in Small-Cell Lung Cancer: The Lowest Common Denominator

1 reference

https://pubmed.ncbi.nlm.nih.gov/19349543

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Female patients with small cell lung cancer live longer than male patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19349543

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Small-cell lung cancer: treatment progress and prospects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19349543

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2008.20.1061

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33384024&oldid=1915882226"